|
|
||||||||
AJP - Cell Physiology, Vol 273, Issue 2 C703-C709, Copyright © 1997 by American Physiological Society
ARTICLES |
R. Henningsson, P. Alm and I. Lundquist
Department of Pharmacology, University of Lund, Sweden.
Recent observations suggest that carbon monoxide (CO) may serve as a neuroendocrine modulator in hypothalamus. Here we provide evidence, for the first time, that the islets of Langerhans contain the constitutive isoform of the CO-producing enzyme heme oxygenase (HO-2), the activity of which was found to modulate islet hormone release. Most insulin and glucagon cells in the rat endocrine pancreas expressed strong immunoreactivity for HO-2. In the exocrine parenchyma, scattered HO-2-positive ganglionic cell bodies were occasionally observed. Furthermore, Western blot analysis revealed the presence of HO-2 in isolated islets but not in acinar cells. Islet homogenates displayed a comparatively high HO-2 enzymatic activity measured as CO formation (approximately 600 pmol CO.min-1.mg islet protein-1). This HO-2 enzymatic activity was greatly suppressed by zincprotoporphyrin-IX (ZnPP-IX), a recognized inhibitor of HO activity. Neither ZnPP-IX nor the HO activator, hemin, influenced basal insulin release from isolated rat islets at low (1 mM) glucose. However, glucagon release at 1 mM glucose was increased by hemin and inhibited by ZnPP-IX. The hemin-induced increase in glucagon secretion was abolished by ZnPP-IX. Furthermore, a series of experiments at high glucose (16.7 mM) revealed that hemin induced a dose-dependent potentiation of glucose-stimulated insulin release. Moreover, glucose-induced insulin release was dose-dependently suppressed by ZnPP-IX but unaffected by protoporphyrin-IX, a compound known not to influence HO-2 activity in other tissues. Similarly, glucagon release at high glucose was dose-dependently increased by hemin and suppressed by ZnPP-IX. Finally, the hemin-induced increase in islet hormone release at high glucose was totally abolished by ZnPP-IX. The data strongly suggest that CO production positively modulates both glucagon and insulin secretion. We propose that CO may serve as a novel messenger molecule within the islets of Langerhans.
This article has been cited by other articles:
![]() |
J. F. Ndisang, N. Lane, and A. Jadhav Upregulation of the heme oxygenase system ameliorates postprandial and fasting hyperglycemia in type 2 diabetes Am J Physiol Endocrinol Metab, May 1, 2009; 296(5): E1029 - E1041. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Ndisang and A. Jadhav Heme oxygenase system enhances insulin sensitivity and glucose metabolism in streptozotocin-induced diabetes Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E829 - E841. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wu and R. Wang Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications Pharmacol. Rev., December 1, 2005; 57(4): 585 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Lundquist, P. Alm, A. Salehi, R. Henningsson, E. Grapengiesser, and B. Hellman Carbon monoxide stimulates insulin release and propagates Ca2+ signals between pancreatic {beta}-cells Am J Physiol Endocrinol Metab, November 1, 2003; 285(5): E1055 - E1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Morse and A. M. K. Choi Heme Oxygenase-1 . The "Emerging Molecule" Has Arrived Am. J. Respir. Cell Mol. Biol., July 1, 2002; 27(1): 8 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pileggi, R. D. Molano, T. Berney, P. Cattan, C. Vizzardelli, R. Oliver, C. Fraker, C. Ricordi, R. L. Pastori, F. H. Bach, et al. Heme Oxygenase-1 Induction in Islet Cells Results in Protection From Apoptosis and Improved In Vivo Function After Transplantation Diabetes, September 1, 2001; 50(9): 1983 - 1991. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Henningsson, P. Alm, and I. Lundquist Evaluation of islet heme oxygenase-CO and nitric oxide synthase-NO pathways during acute endotoxemia Am J Physiol Cell Physiol, May 1, 2001; 280(5): C1242 - C1254. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wang, Z. Wang, L. Wu, S. T. Hanna, and R. Peterson-Wakeman Reduced Vasorelaxant Effect of Carbon Monoxide in Diabetes and the Underlying Mechanisms Diabetes, January 1, 2001; 50(1): 166 - 174. [Abstract] [Full Text] |
||||
![]() |
L. E. Otterbein and A. M. K. Choi Heme oxygenase: colors of defense against cellular stress Am J Physiol Lung Cell Mol Physiol, December 1, 2000; 279(6): L1029 - L1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Henningsson, P. Alm, E. Lindstrom, and I. Lundquist Chronic blockade of NO synthase paradoxically increases islet NO production and modulates islet hormone release Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E95 - E107. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Paredi, W. Biernacki, G. Invernizzi, S. A. Kharitonov, and P. J. Barnes Exhaled Carbon Monoxide Levels Elevated in Diabetes and Correlated With Glucose Concentration in Blood: A New Test for Monitoring the Disease? Chest, October 1, 1999; 116(4): 1007 - 1011. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |